Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Guelph

$135,000.00

Control of neuron growth and depressive-like behavior by adaptor protein ShcD.

FY 2021-22

Summary
The prevalence of mental illness is increasing, and it is estimated that mental health problems affect 1 in 5 Canadians over a lifetime. Mental disorders remain challenging to diagnose and treat since there is no direct genetic or anatomic locus that is causative. Impairments in adult neurogenesis (the birth of new neurons) have been identified in several mental health disorders such as major depressive disorder (MDD), and treatments that improve mental illness or its symptoms enhance neurogenesis. Presently however, the molecular mechanisms linking neurogenesis to these disorders remain poorly understood, limiting opportunities for development of new therapies. The ShcD adaptor is a newly identified molecule that mediates neuronal signal transduction. Our lab has recently shown that ShcD is expressed in the developing and adult brain, particularly in regions associated with neurogenesis, and that ShcD knockout mice have alterations in these structures. Moreover, variants in the ShcD gene in humans have been correlated with mental disorders including MDD. Together these findings suggest that deviations in ShcD expression and/or activity affect neurodevelopment in ways that increase susceptibility to certain mental illnesses. My research aims to identify the function of ShcD in neurodevelopment and disorder by combining multiple sophisticated tools. First, I will manipulate ShcD expression via gene editing in human stem cells, which will be differentiated to form neurons or cerebral organoids (mini-brains). The impact of loss or gain of ShcD will be assessed using imaging techniques and signaling assays. Second, ShcD knockout mice will be subject to chronic stress and tested for development of depression-like responses, as well as evidence of neurogenesis. Altogether, this research represents a powerful approach to enhance our understanding of ShcD in neurobiology, as well as guide future studies to improve diagnosis and treatment of neuropsychiatric disorders.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
454687
Name
Alural Begum
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Control of neuron growth and depressive-like behavior by adaptor protein ShcD.
Programtype2
Fellowship Programs
Orgnameinp2
University of Guelph
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Behavioural Neuroscience; Cerebral Organoids; Depression; Molecular Neuroscience; Neurodevelopment; Neurogenesis; Sex Differences; Stress
Abstract
The prevalence of mental illness is increasing, and it is estimated that mental health problems affect 1 in 5 Canadians over a lifetime. Mental disorders remain challenging to diagnose and treat since there is no direct genetic or anatomic locus that is causative. Impairments in adult neurogenesis (the birth of new neurons) have been identified in several mental health disorders such as major depressive disorder (MDD), and treatments that improve mental illness or its symptoms enhance neurogenesis. Presently however, the molecular mechanisms linking neurogenesis to these disorders remain poorly understood, limiting opportunities for development of new therapies. The ShcD adaptor is a newly identified molecule that mediates neuronal signal transduction. Our lab has recently shown that ShcD is expressed in the developing and adult brain, particularly in regions associated with neurogenesis, and that ShcD knockout mice have alterations in these structures. Moreover, variants in the ShcD gene in humans have been correlated with mental disorders including MDD. Together these findings suggest that deviations in ShcD expression and/or activity affect neurodevelopment in ways that increase susceptibility to certain mental illnesses. My research aims to identify the function of ShcD in neurodevelopment and disorder by combining multiple sophisticated tools. First, I will manipulate ShcD expression via gene editing in human stem cells, which will be differentiated to form neurons or cerebral organoids (mini-brains). The impact of loss or gain of ShcD will be assessed using imaging techniques and signaling assays. Second, ShcD knockout mice will be subject to chronic stress and tested for development of depression-like responses, as well as evidence of neurogenesis. Altogether, this research represents a powerful approach to enhance our understanding of ShcD in neurobiology, as well as guide future studies to improve diagnosis and treatment of neuropsychiatric disorders.
Competitiondate
202110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Alural, Begum
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~
University of Guelph - $135,000 Grant (2021-22) | Canada Spends